Theraclion Valuation

Is 941 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 941 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 941's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 941's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 941?

Key metric: As 941 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 941. This is calculated by dividing 941's market cap by their current revenue.
What is 941's PS Ratio?
PS Ratio13.1x
Sales€1.28m
Market Cap€16.85m

Price to Sales Ratio vs Peers

How does 941's PS Ratio compare to its peers?

The above table shows the PS ratio for 941 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.8x
AAQ1 aap Implantate
1.9xn/a€22.4m
GME Geratherm Medical
0.8x1.9%€15.0m
AUG Audientes
12.6xn/a€6.9m
PUS PULSION Medical Systems
3.8xn/a€134.4m
941 Theraclion
13.1xn/a€16.8m

Price-To-Sales vs Peers: 941 is expensive based on its Price-To-Sales Ratio (13.1x) compared to the peer average (2.1x).


Price to Sales Ratio vs Industry

How does 941's PS Ratio compare vs other companies in the DE Medical Equipment Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
DRW3 Drägerwerk KGaA
0.2x4.2%US$828.96m
PHH2 Paul Hartmann
0.3xn/aUS$773.00m
U4W0 Quotient
0.07xn/aUS$2.78m
MF6 MagForce
0.3xn/aUS$404.27k
No more companies available in this PS range
941 13.1xIndustry Avg. 3.4xNo. of Companies4PS01.63.24.86.48+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 941 is expensive based on its Price-To-Sales Ratio (13.1x) compared to the European Medical Equipment industry average (3.4x).


Price to Sales Ratio vs Fair Ratio

What is 941's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

941 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio13.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 941's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies